News from the healthcare data industry
Digital Front Door automates the true patient journey and accelerates RWE SAN DIEGO, July 28, 2022 /PRNewswire/ — Seqster PDM, Inc. (“Seqster“), the leader in patient-centric healthcare data technology announced a 3-year...
Published in PNAS Nexus, this study has the ability to impact future research and inform more proactive and sustainable pandemic preparedness July 20, 2022 08:47 AM Eastern Daylight Time CAMBRIDGE,...
Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease July 13, 2022 08:47 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS...
Pfizer India has signed a Memorandum of Understanding (MoU) with Max Super Specialty Hospitals to give fellowships to young doctors in 17 Max Hospitals to gather real-world evidence on drug...
July 12, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)–Turquoise Health and Komodo Health announced a partnership today to expand the depth of healthcare insights that...
CHICAGO and SINGAPORE, July 12, 2022 /PRNewswire/ — EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters in Singapore and offices across Japan, China and other countries in the area, and...
Jun 30, 2022 | staff reporter NEW YORK – A pan-cancer analysis involving tens of thousands of patients has spelled out new and known relationships between tumor mutations, survival outcomes, and responses...
Abstract Quantifying the effectiveness of different cancer therapies in patients with specific tumor mutations is critical for improving patient outcomes and advancing precision medicine. Here we perform a large-scale computational...
NEW YORK and OTTAWA, ON and TUCSON, Ariz., June 29, 2022 /PRNewswire/ – Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, announced today a new partnership that involves leveraging synthetic data to further catalyze...
CHICAGO, June 29, 2022 /PRNewswire/ — EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., today announced a partnership...